Skip to main navigation Skip to search Skip to main content

Die medikamenten-induzierte Dysfunktion der Harnblase

  • T. Schneider
  • , H. Rübben
  • , M. C. Michel

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Bladder dysfunction can result from pathological changes in the bladder itself, of its central neurological regulation, (BPS), or of non-urological diseases such as diabetes or heart failure. Medication-induced bladder dysfunction can mostly be treated by simple changes in the pharmacological therapy. Bladder dysfunction can be induced pharmacologically by activating or inhibitory influences on adrenergic, sympathetic, beta-receptor-induced relaxation of the detrusor, alpha-receptor-induced contraction of the bladder neck, or cholinergic, parasympathetic, muscarinic receptor-induced contraction of the detrusor. Diuretics can increase urine production, thus possibly leading to incontinence. If incontinence occurs in patients, treatment should be stopped if possible and additional pharmacological therapy should not be started before medication-induced bladder dysfunction is excluded
Original languageEnglish
Pages (from-to)1588-1593
JournalUrologe. Ausg. A
Volume42
Issue number12
DOIs
Publication statusPublished - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Die medikamenten-induzierte Dysfunktion der Harnblase'. Together they form a unique fingerprint.

Cite this